413 related articles for article (PubMed ID: 15197087)
21. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
[TBL] [Abstract][Full Text] [Related]
22. Factors predicting failure to identify a sentinel lymph node in breast cancer.
Chagpar AB; Martin RC; Scoggins CR; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
Surgery; 2005 Jul; 138(1):56-63. PubMed ID: 16003317
[TBL] [Abstract][Full Text] [Related]
23. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.
Yen RF; Kuo WH; Lien HC; Chen TH; Jan IS; Wu YW; Wang MY; Chang KJ; Huang CS
J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970
[TBL] [Abstract][Full Text] [Related]
24. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy.
Sanidas EE; Daskalakis M; Sbyrakis N; Tsiftsis DD
Eur J Surg Oncol; 2005 May; 31(4):357-63. PubMed ID: 15837039
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative injection of subareolar or dermal radioisotope results in predictable identification of sentinel lymph nodes in breast cancer.
Johnson CB; Boneti C; Korourian S; Adkins L; Klimberg VS
Ann Surg; 2011 Oct; 254(4):612-8. PubMed ID: 21918427
[TBL] [Abstract][Full Text] [Related]
26. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.
McMasters KM; Wong SL; Martin RC; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Laidley AL; McGlothin TQ; Ley PB; Brown CM; Glaser RL; Pennington RE; Turk PS; Simpson D; Cerrito PB; Edwards MJ;
Ann Surg; 2001 May; 233(5):676-87. PubMed ID: 11360892
[TBL] [Abstract][Full Text] [Related]
27. Periareolar injection for localization of sentinel nodes in breast cancer patients.
Ellis RL; Seifert PJ; Neal CE; Pavolka KR; Mann JL; Malafa MP; Wichterman KA; Ross DS; Dunnington GL
Breast J; 2004; 10(2):94-100. PubMed ID: 15009034
[TBL] [Abstract][Full Text] [Related]
28. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer.
Vargas HI; Tolmos J; Agbunag RV; Mishkin F; Vargas MP; Diggles L; Gonzalez KD; Venegas R; Klein SR; Khalkhali I
Am Surg; 2002 Jan; 68(1):87-91. PubMed ID: 12467326
[TBL] [Abstract][Full Text] [Related]
29. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
Murawa D; Hirche C; Dresel S; Hünerbein M
Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
Ge J; Yan B; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
[TBL] [Abstract][Full Text] [Related]
33. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
34. Improved lymphatic mapping technique for breast cancer.
Beitsch PD; Clifford E; Whitworth P; Abarca A
Breast J; 2001; 7(4):219-23. PubMed ID: 11678798
[TBL] [Abstract][Full Text] [Related]
35. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer.
Kaklamanos IG; Birbas K; Syrigos K; Bonatsos VG; Bonatsos G
J Surg Oncol; 2011 Jul; 104(1):37-40. PubMed ID: 21360537
[TBL] [Abstract][Full Text] [Related]
36. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers.
Wong SL; Chao C; Edwards MJ; Tuttle TM; Noyes RD; Carlson DJ; Laidley AL; McGlothin TQ; Ley PB; Brown CM; Glaser RL; Pennington RE; Turk PS; Simpson D; McMasters KM
Am Surg; 2001 Jun; 67(6):522-6; discussion 527-8. PubMed ID: 11409798
[TBL] [Abstract][Full Text] [Related]
38. Radioguided sentinel lymph node biopsy in early breast cancer: experience at Chang Gung Memorial Hospital.
Lo YF; Hsueh S; Ma SY; Chen SC; Chen MF
Chang Gung Med J; 2006; 29(5):458-67. PubMed ID: 17214389
[TBL] [Abstract][Full Text] [Related]
39. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
40. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.
Rodier JF; Velten M; Wilt M; Martel P; Ferron G; Vaini-Elies V; Mignotte H; Brémond A; Classe JM; Dravet F; Routiot T; de Lara CT; Avril A; Lorimier G; Fondrinier E; Houvenaeghel G; Avigdor S
J Clin Oncol; 2007 Aug; 25(24):3664-9. PubMed ID: 17485709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
